| SECTOR | INDUSTRY |
| Health Care | Biotechnology |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | BIAF | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.3 | $273.0 | 2% |
|
| Shares Out (Mil) | 5.2 | 53.1 | 14% |
|
| Institutional Ownership | 78.4% | 92.4% | 48% |
|
| Float (Mil) | 8.0 | 40.1 | 17% |
|
| Beta | -1.05 | 0.94 | 1% |
|
| Avg Daily Volume (000s) | 360 | 496 | 52% |
|
| Price Change (52-week) |
(95.2%) | 57.5% | 2% |
|
| Growth | BIAF | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (15.3%) | (10.0%) | 25% |
|
| EPS (5yr) | 36.1% | 16.0% | 86 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 20.7% | (15.6%) | 80% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BIAF | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6 | $37 | 7% |
|
| Net Income (TTM) (Mil) | ($15) | ($43) | 26% |
|
| EPS (TTM) | ($3.980) | ($1.500) | 9% |
|
| Operating Cash Flow (TTM) (Mil) | ($12) | ($31) | 19% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $2 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $4 | 18% |
|
| Enterprise Value (Q1) (Mil) | $3 | $166 | 5% |
|
| Valuation | BIAF | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.72 | 2.71 | 13% |
|
| P/E | na | 18.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.9 | na |
|
| Ratios | BIAF | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 34.6% | 64.2% | 42% |
|
| Net Margin | (257.3%) | (73.0%) | 4% |
|
| ROA | (245.5%) | (47.7%) | 1% |
|
| ROE | na | (55.1%) | na |
|
| Liabilities to Assets | 50.5% | 29.8% | 43% |
|
| F-Score | 3 | 3 | 18% |
|
bioAffinity Technologies, Inc. did not pass any screens on 8/14/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
